Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1000 participants.

Also called NCT06102031

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06102031
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06102031. Randomized; no masking; primary purpose treatment. Start 2023-11 (anticipated); primary completion 2025-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure
Condition
Heart Failure
Intervention (Device)
ReDS-Guided
Intervention (Other)
Usual care
Lead sponsor
Shanghai Zhongshan Hospital (class: other)

Record details

Record id
cardio:ct-nct06102031
Content hash
be179619c9f5e13f6a5f66b79b101d11feaa72c04488264ba641250738a5c848